WO2002022807A3 - Nouvelles proteines et molecules d'acide nucleique de dermatophagoides et leurs utilisations - Google Patents

Nouvelles proteines et molecules d'acide nucleique de dermatophagoides et leurs utilisations Download PDF

Info

Publication number
WO2002022807A3
WO2002022807A3 PCT/US2001/028730 US0128730W WO0222807A3 WO 2002022807 A3 WO2002022807 A3 WO 2002022807A3 US 0128730 W US0128730 W US 0128730W WO 0222807 A3 WO0222807 A3 WO 0222807A3
Authority
WO
WIPO (PCT)
Prior art keywords
proteins
dermatophagoides
nucleic acid
acid molecules
therapeutic
Prior art date
Application number
PCT/US2001/028730
Other languages
English (en)
Other versions
WO2002022807A2 (fr
Inventor
Catherine A Mccall
Shirley Wu Hunter
Eric R Weber
Original Assignee
Heska Corp
Catherine A Mccall
Shirley Wu Hunter
Eric R Weber
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/662,293 external-priority patent/US7128921B1/en
Application filed by Heska Corp, Catherine A Mccall, Shirley Wu Hunter, Eric R Weber filed Critical Heska Corp
Priority to AU2001292661A priority Critical patent/AU2001292661A1/en
Priority to JP2002527249A priority patent/JP2004529605A/ja
Priority to EP01973039A priority patent/EP1328625A2/fr
Priority to CA002420459A priority patent/CA2420459A1/fr
Publication of WO2002022807A2 publication Critical patent/WO2002022807A2/fr
Publication of WO2002022807A3 publication Critical patent/WO2002022807A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43531—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from mites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Insects & Arthropods (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne des protéines de Dermatophagoïdes de poids moléculaire élevée, des molécules d'acide nucléique codant ces protéines, ainsi que des réactifs thérapeutiques et diagnostiques obtenus à partir de ces protéines.
PCT/US2001/028730 2000-09-14 2001-09-14 Nouvelles proteines et molecules d'acide nucleique de dermatophagoides et leurs utilisations WO2002022807A2 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
AU2001292661A AU2001292661A1 (en) 2000-09-14 2001-09-14 Novel dermatophagoides nucleic acid molecules, proteins and uses thereof
JP2002527249A JP2004529605A (ja) 2000-09-14 2001-09-14 Ｄｅｒｍａｔｏｐｈａｇｏｉｄｅｓ核酸分子、タンパク質およびそれらの使用
EP01973039A EP1328625A2 (fr) 2000-09-14 2001-09-14 Nouvelles proteines et molecules d'acide nucleique de dermatophagoides et leurs utilisations
CA002420459A CA2420459A1 (fr) 2000-09-14 2001-09-14 Nouvelles proteines et molecules d'acide nucleique de dermatophagoides et leurs utilisations

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/662,293 2000-09-14
US09/662,293 US7128921B1 (en) 1998-04-17 2000-09-14 Dermatophagoides proteins and fragments thereof

Publications (2)

Publication Number Publication Date
WO2002022807A2 WO2002022807A2 (fr) 2002-03-21
WO2002022807A3 true WO2002022807A3 (fr) 2003-05-22

Family

ID=24657158

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/028730 WO2002022807A2 (fr) 2000-09-14 2001-09-14 Nouvelles proteines et molecules d'acide nucleique de dermatophagoides et leurs utilisations

Country Status (5)

Country Link
EP (1) EP1328625A2 (fr)
JP (1) JP2004529605A (fr)
AU (1) AU2001292661A1 (fr)
CA (1) CA2420459A1 (fr)
WO (1) WO2002022807A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106146640B (zh) * 2016-05-31 2019-10-22 深圳大学 尘螨变应原及其应用
EP3661603A1 (fr) * 2017-07-31 2020-06-10 Laboratorios LETI, S.L. Unipersonal Produit vétérinaire

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999054349A2 (fr) * 1998-04-17 1999-10-28 Heska Corporation Molecules d'acides nucleiques dermatophagoides, proteines et leurs utilisations

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999054349A2 (fr) * 1998-04-17 1999-10-28 Heska Corporation Molecules d'acides nucleiques dermatophagoides, proteines et leurs utilisations

Also Published As

Publication number Publication date
JP2004529605A (ja) 2004-09-30
WO2002022807A2 (fr) 2002-03-21
CA2420459A1 (fr) 2002-03-21
EP1328625A2 (fr) 2003-07-23
AU2001292661A1 (en) 2002-03-26

Similar Documents

Publication Publication Date Title
WO2002002624A3 (fr) Molecules de type b7 et utilisation de ces molecules
AU2002218166A1 (en) Collections of repeat proteins comprising repeat modules
WO2002024891A3 (fr) Molecules semblables a b7 (b7-like, b7-l) et utilisations correspondantes
WO2002014485A3 (fr) Nouveau gene kallikreine
WO2002008285A3 (fr) Molecules il-17 et leurs utilisations
AU2002252436A1 (en) Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
WO1999054349A3 (fr) Molecules d'acides nucleiques dermatophagoides, proteines et leurs utilisations
WO2001059120A3 (fr) Molecules de type il-17 et utilisation de ces dernieres
WO2001066752A3 (fr) Genes specifiques de la reproduction
WO2002022807A3 (fr) Nouvelles proteines et molecules d'acide nucleique de dermatophagoides et leurs utilisations
AU2002364691A1 (en) Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
WO2002079384A9 (fr) Proteines transporteurs humaines isolees, molecules d'acides nucleiques codant ces proteines transporteurs humaines et utilisations correspondantes
WO2001051518A3 (fr) Molecules d'acide nucleique isolees codant pour une molecule de semaphorine humaine et utilisations correspondantes
ZA99445B (en) Isolated, polypeptides which bind to HLA-A29 molecules nucleic acid, the molecules encoding these, and uses thereof.
WO2002063013A3 (fr) Nouveau gene de phosphatase acide
AU2001253804A1 (en) Isolated human transporter proteins, nucleic acid molecules encoding the same, and uses thereof
AU2002359335A1 (en) Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
WO2003031639A8 (fr) Cryopyrines isolees, molecules d'acides nucleiques codant ces proteines, et utilisations correspondantes
AU2002258618A1 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
AU2002243459A1 (en) Isolated human phosphodiesterase proteins, nucleic acid molecules encoding human phosphodiesterase proteins, and uses thereof
AU2002307033A1 (en) Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
WO2002062845A3 (fr) Molecules d'adhesion
WO2002000710A3 (fr) Molecules de type b7 et utilisations associees
WO2002050116A3 (fr) Proteine molecule d'adhesion
AU2002311750A1 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2420459

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2001292661

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2002527249

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2001973039

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2001973039

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 2001973039

Country of ref document: EP